Oligonucleotides Market Report

Europe Oligonucleotides Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 18, 2020
  • PAGES：217
  • REPORT CODE：GMM556488
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Oligonucleotides market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.3% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Oligonucleotides Market Segmentations:

    By Player:

    • Beijing SBS Genetech

    • Eurofins Genomics

    • BGI

    • AM Chemicals

    • DNA Services Core

    • Biolegio

    • AltaBioscience

    • Eton Bioscience Inc

    • Oligo Factory

    • Creative Biogene

    • Biomatik

    • Exiqon

    • Sigma-Aldrich

    • IDT

    • TAG Copenhagen

    • Ella Biotech

    • AM Biotechnologies LLC

    • TriLink BioTechnologies

    • Microsynth AG

    • Syntezza Bioscience

    • Bio Basic

    • ThermoFisher

    • Life biotech

    • SGS DNA

    • Bioneer

    By Type:

    • DNA Oligomers

    • RNA Oligomers

    By End-User:

    • Genetic Testing

    • Research

    • Forensics

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oligonucleotides Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Oligonucleotides Market Size and Growth Rate of DNA Oligomers from 2014 to 2026

    • 1.3.2 Europe Oligonucleotides Market Size and Growth Rate of RNA Oligomers from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Oligonucleotides Market Size and Growth Rate of Genetic Testing from 2014 to 2026

    • 1.4.2 Europe Oligonucleotides Market Size and Growth Rate of Research from 2014 to 2026

    • 1.4.3 Europe Oligonucleotides Market Size and Growth Rate of Forensics from 2014 to 2026

    • 1.4.4 Europe Oligonucleotides Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Oligonucleotides Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Oligonucleotides Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Oligonucleotides Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Oligonucleotides Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Oligonucleotides Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Oligonucleotides Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Oligonucleotides Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Oligonucleotides Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Oligonucleotides Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oligonucleotides Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Oligonucleotides Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Oligonucleotides Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oligonucleotides by Major Types

      • 3.4.1 Market Size and Growth Rate of DNA Oligomers

      • 3.4.2 Market Size and Growth Rate of RNA Oligomers

    4 Segmentation of Oligonucleotides Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oligonucleotides by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Genetic Testing for Construction

      • 4.4.2 Market Size and Growth Rate of Research for Construction

      • 4.4.3 Market Size and Growth Rate of Forensics for Construction

      • 4.4.4 Market Size and Growth Rate of Others for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Oligonucleotides Production Analysis by Top Regions

    • 5.2 Europe Oligonucleotides Consumption Analysis by Top Regions

    • 5.3 Europe Oligonucleotides Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Oligonucleotides Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Oligonucleotides Production, Import, Consumption and Export Analysis

      • 5.3.3 France Oligonucleotides Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Oligonucleotides Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Oligonucleotides Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Oligonucleotides Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Oligonucleotides Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Oligonucleotides Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Oligonucleotides Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oligonucleotides Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Oligonucleotides Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Oligonucleotides Production, Import, Consumption and Export Analysis

    6 Product Circulation of Oligonucleotides Market among Top Countries

    • 6.1 Top 5 Export Countries in Oligonucleotides Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Oligonucleotides Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Oligonucleotides Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Oligonucleotides Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Oligonucleotides Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Oligonucleotides Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Oligonucleotides Landscape Analysis

    • 7.1 Germany Oligonucleotides Landscape Analysis by Major Types

    • 7.2 Germany Oligonucleotides Landscape Analysis by Major End-Users

    8. UK Oligonucleotides Landscape Analysis

    • 8.1 UK Oligonucleotides Landscape Analysis by Major Types

    • 8.2 UK Oligonucleotides Landscape Analysis by Major End-Users

    9. France Oligonucleotides Landscape Analysis

    • 9.1 France Oligonucleotides Landscape Analysis by Major Types

    • 9.2 France Oligonucleotides Landscape Analysis by Major End-Users

    10. Italy Oligonucleotides Landscape Analysis

    • 10.1 Italy Oligonucleotides Landscape Analysis by Major Types

    • 10.2 Italy Oligonucleotides Landscape Analysis by Major End-Users

    11. Spain Oligonucleotides Landscape Analysis

    • 11.1 Spain Oligonucleotides Landscape Analysis by Major Types

    • 11.2 Spain Oligonucleotides Landscape Analysis by Major End-Users

    12. Poland Oligonucleotides Landscape Analysis

    • 12.1 Poland Oligonucleotides Landscape Analysis by Major Types

    • 12.2 Poland Oligonucleotides Landscape Analysis by Major End-Users

    13. Russia Oligonucleotides Landscape Analysis

    • 13.1 Russia Oligonucleotides Landscape Analysis by Major Types

    • 13.2 Russia Oligonucleotides Landscape Analysis by Major End-Users

    14. Switzerland Oligonucleotides Landscape Analysis

    • 14.1 Switzerland Oligonucleotides Landscape Analysis by Major Types

    • 14.2 Switzerland Oligonucleotides Landscape Analysis by Major End-Users

    15. Turkey Oligonucleotides Landscape Analysis

    • 15.1 Turkey Oligonucleotides Landscape Analysis by Major Types

    • 15.2 Turkey Oligonucleotides Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oligonucleotides Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oligonucleotides Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oligonucleotides Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oligonucleotides Landscape Analysis by Top Countries

      • 16.3.1 Denmark Oligonucleotides Market Volume and Growth Rate

      • 16.3.2 Finland Oligonucleotides Market Volume and Growth Rate

      • 16.3.3 Norway Oligonucleotides Market Volume and Growth Rate

      • 16.3.4 Sweden Oligonucleotides Market Volume and Growth Rate

      • 16.3.6 Iceland Oligonucleotides Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Oligonucleotides Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Oligonucleotides Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Oligonucleotides Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Oligonucleotides Landscape Analysis by Top Countries

      • 17.3.1 Belgium Oligonucleotides Market Volume and Growth Rate

      • 17.3.2 Netherlands Oligonucleotides Market Volume and Growth Rate

      • 17.3.3 Luxembourg Oligonucleotides Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Oligonucleotides Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Oligonucleotides Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Oligonucleotides Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Oligonucleotides Landscape Analysis by Top Countries

      • 18.3.1 Estonia Oligonucleotides Market Volume and Growth Rate

      • 18.3.2 Latvia Oligonucleotides Market Volume and Growth Rate

      • 18.3.3 Lithuania Oligonucleotides Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Beijing SBS Genetech

      • 19.1.1 Beijing SBS Genetech Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Eurofins Genomics

      • 19.2.1 Eurofins Genomics Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 BGI

      • 19.3.1 BGI Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 AM Chemicals

      • 19.4.1 AM Chemicals Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 DNA Services Core

      • 19.5.1 DNA Services Core Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Biolegio

      • 19.6.1 Biolegio Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 AltaBioscience

      • 19.7.1 AltaBioscience Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Eton Bioscience Inc

      • 19.8.1 Eton Bioscience Inc Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Oligo Factory

      • 19.9.1 Oligo Factory Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Creative Biogene

      • 19.10.1 Creative Biogene Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Biomatik

      • 19.11.1 Biomatik Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Exiqon

      • 19.12.1 Exiqon Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Sigma-Aldrich

      • 19.13.1 Sigma-Aldrich Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 IDT

      • 19.14.1 IDT Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 TAG Copenhagen

      • 19.15.1 TAG Copenhagen Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Ella Biotech

      • 19.16.1 Ella Biotech Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 AM Biotechnologies LLC

      • 19.17.1 AM Biotechnologies LLC Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 TriLink BioTechnologies

      • 19.18.1 TriLink BioTechnologies Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Microsynth AG

      • 19.19.1 Microsynth AG Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Syntezza Bioscience

      • 19.20.1 Syntezza Bioscience Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Bio Basic

      • 19.21.1 Bio Basic Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 ThermoFisher

      • 19.22.1 ThermoFisher Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    • 19.23 Life biotech

      • 19.23.1 Life biotech Company Profile and Development Status

      • 19.23.2 Market Performance

      • 19.23.3 Product and Service Introduction

    • 19.24 SGS DNA

      • 19.24.1 SGS DNA Company Profile and Development Status

      • 19.24.2 Market Performance

      • 19.24.3 Product and Service Introduction

    • 19.25 Bioneer

      • 19.25.1 Bioneer Company Profile and Development Status

      • 19.25.2 Market Performance

      • 19.25.3 Product and Service Introduction

    The List of Tables and Figures (Totals 77 Figures and 139 Tables)

    • Figure Product Picture

    • Figure Oligonucleotides Market Size and Growth Rate of DNA Oligomers Market, 2015 - 2026 (USD Million)

    • Figure Oligonucleotides Market Size and Growth Rate of RNA Oligomers Market, 2015 - 2026 (USD Million)

    • Figure Oligonucleotides Market Size and Growth Rate of Genetic Testing from 2014 to 2026

    • Figure Oligonucleotides Market Size and Growth Rate of Research from 2014 to 2026

    • Figure Oligonucleotides Market Size and Growth Rate of Forensics from 2014 to 2026

    • Figure Oligonucleotides Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure UK Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure France Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Oligonucleotides Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Oligonucleotides Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Oligonucleotides

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oligonucleotides by Different Types from 2014 to 2026

    • Table Consumption Share of Oligonucleotides by Different Types from 2014 to 2026

    • Figure Oligonucleotides Market Size and Growth Rate of DNA Oligomers Market, 2015 - 2026 (USD Million)

    • Figure Oligonucleotides Market Size and Growth Rate of RNA Oligomers Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Oligonucleotides by Different End-Users from 2014 to 2026

    • Table Consumption Share of Oligonucleotides by Different End-Users from 2014 to 2026

    • Figure Oligonucleotides Market Size and Growth Rate of Genetic Testing from 2014 to 2026

    • Figure Oligonucleotides Market Size and Growth Rate of Research from 2014 to 2026

    • Figure Oligonucleotides Market Size and Growth Rate of Forensics from 2014 to 2026

    • Figure Oligonucleotides Market Size and Growth Rate of Others from 2014 to 2026

    • Table Europe Oligonucleotides Production by Major Regions

    • Table Europe Oligonucleotides Production Share by Major Regions

    • Figure Europe Oligonucleotides Production Share by Major Countries and Regions in 2014

    • Table Europe Oligonucleotides Consumption by Major Regions

    • Table Europe Oligonucleotides Consumption Share by Major Regions

    • Table Germany Oligonucleotides Production, Import, Consumption and Export Analysis

    • Table UK Oligonucleotides Production, Import, Consumption and Export Analysis

    • Table France Oligonucleotides Production, Import, Consumption and Export Analysis

    • Table Italy Oligonucleotides Production, Import, Consumption and Export Analysis

    • Table Spain Oligonucleotides Production, Import, Consumption and Export Analysis

    • Table Poland Oligonucleotides Production, Import, Consumption and Export Analysis

    • Table Russia Oligonucleotides Production, Import, Consumption and Export Analysis

    • Table Switzerland Oligonucleotides Production, Import, Consumption and Export Analysis

    • Table Turkey Oligonucleotides Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oligonucleotides Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oligonucleotides Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oligonucleotides Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Oligonucleotides Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Oligonucleotides Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Oligonucleotides Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Oligonucleotides Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Oligonucleotides Consumption by Types from 2014 to 2026

    • Table Germany Oligonucleotides Consumption Share by Types from 2014 to 2026

    • Table Germany Oligonucleotides Consumption by End-Users from 2014 to 2026

    • Table Germany Oligonucleotides Consumption Share by End-Users from 2014 to 2026

    • Table UK Oligonucleotides Consumption by Types from 2014 to 2026

    • Table UK Oligonucleotides Consumption Share by Types from 2014 to 2026

    • Table UK Oligonucleotides Consumption by End-Users from 2014 to 2026

    • Table UK Oligonucleotides Consumption Share by End-Users from 2014 to 2026

    • Table France Oligonucleotides Consumption by Types from 2014 to 2026

    • Table France Oligonucleotides Consumption Share by Types from 2014 to 2026

    • Table France Oligonucleotides Consumption by End-Users from 2014 to 2026

    • Table France Oligonucleotides Consumption Share by End-Users from 2014 to 2026

    • Table Italy Oligonucleotides Consumption by Types from 2014 to 2026

    • Table Italy Oligonucleotides Consumption Share by Types from 2014 to 2026

    • Table Italy Oligonucleotides Consumption by End-Users from 2014 to 2026

    • Table Italy Oligonucleotides Consumption Share by End-Users from 2014 to 2026

    • Table Spain Oligonucleotides Consumption by Types from 2014 to 2026

    • Table Spain Oligonucleotides Consumption Share by Types from 2014 to 2026

    • Table Spain Oligonucleotides Consumption by End-Users from 2014 to 2026

    • Table Spain Oligonucleotides Consumption Share by End-Users from 2014 to 2026

    • Table Poland Oligonucleotides Consumption by Types from 2014 to 2026

    • Table Poland Oligonucleotides Consumption Share by Types from 2014 to 2026

    • Table Poland Oligonucleotides Consumption by End-Users from 2014 to 2026

    • Table Poland Oligonucleotides Consumption Share by End-Users from 2014 to 2026

    • Table Russia Oligonucleotides Consumption by Types from 2014 to 2026

    • Table Russia Oligonucleotides Consumption Share by Types from 2014 to 2026

    • Table Russia Oligonucleotides Consumption by End-Users from 2014 to 2026

    • Table Russia Oligonucleotides Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Oligonucleotides Consumption by Types from 2014 to 2026

    • Table Switzerland Oligonucleotides Consumption Share by Types from 2014 to 2026

    • Table Switzerland Oligonucleotides Consumption by End-Users from 2014 to 2026

    • Table Switzerland Oligonucleotides Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Oligonucleotides Consumption by Types from 2014 to 2026

    • Table Turkey Oligonucleotides Consumption Share by Types from 2014 to 2026

    • Table Turkey Oligonucleotides Consumption by End-Users from 2014 to 2026

    • Table Turkey Oligonucleotides Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oligonucleotides Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oligonucleotides Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oligonucleotides Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oligonucleotides Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oligonucleotides Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oligonucleotides Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Oligonucleotides Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Oligonucleotides Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Oligonucleotides Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Oligonucleotides Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Oligonucleotides Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oligonucleotides Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oligonucleotides Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oligonucleotides Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oligonucleotides Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oligonucleotides Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oligonucleotides Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Oligonucleotides Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Oligonucleotides Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Oligonucleotides Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oligonucleotides Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oligonucleotides Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oligonucleotides Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oligonucleotides Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oligonucleotides Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oligonucleotides Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Oligonucleotides Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Oligonucleotides Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Oligonucleotides Market Volume and Growth Rate from 2014 to 2026

    • Table Beijing SBS Genetech Profiles

    • Table Beijing SBS Genetech Production, Value, Price, Gross Margin 2014-2019

    • Table Beijing SBS Genetech Product benchmarking

    • Table Beijing SBS Genetech Strategic initiatives

    • Table Beijing SBS Genetech SWOT analysis

    • Table Eurofins Genomics Profiles

    • Table Eurofins Genomics Production, Value, Price, Gross Margin 2014-2019

    • Table Eurofins Genomics Product benchmarking

    • Table Eurofins Genomics Strategic initiatives

    • Table Eurofins Genomics SWOT analysis

    • Table BGI Profiles

    • Table BGI Production, Value, Price, Gross Margin 2014-2019

    • Table BGI Product benchmarking

    • Table BGI Strategic initiatives

    • Table BGI SWOT analysis

    • Table AM Chemicals Profiles

    • Table AM Chemicals Production, Value, Price, Gross Margin 2014-2019

    • Table AM Chemicals Product benchmarking

    • Table AM Chemicals Strategic initiatives

    • Table AM Chemicals SWOT analysis

    • Table DNA Services Core Profiles

    • Table DNA Services Core Production, Value, Price, Gross Margin 2014-2019

    • Table DNA Services Core Product benchmarking

    • Table DNA Services Core Strategic initiatives

    • Table DNA Services Core SWOT analysis

    • Table Biolegio Profiles

    • Table Biolegio Production, Value, Price, Gross Margin 2014-2019

    • Table Biolegio Product benchmarking

    • Table Biolegio Strategic initiatives

    • Table Biolegio SWOT analysis

    • Table AltaBioscience Profiles

    • Table AltaBioscience Production, Value, Price, Gross Margin 2014-2019

    • Table AltaBioscience Product benchmarking

    • Table AltaBioscience Strategic initiatives

    • Table AltaBioscience SWOT analysis

    • Table Eton Bioscience Inc Profiles

    • Table Eton Bioscience Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Eton Bioscience Inc Product benchmarking

    • Table Eton Bioscience Inc Strategic initiatives

    • Table Eton Bioscience Inc SWOT analysis

    • Table Oligo Factory Profiles

    • Table Oligo Factory Production, Value, Price, Gross Margin 2014-2019

    • Table Oligo Factory Product benchmarking

    • Table Oligo Factory Strategic initiatives

    • Table Oligo Factory SWOT analysis

    • Table Creative Biogene Profiles

    • Table Creative Biogene Production, Value, Price, Gross Margin 2014-2019

    • Table Creative Biogene Product benchmarking

    • Table Creative Biogene Strategic initiatives

    • Table Creative Biogene SWOT analysis

    • Table Biomatik Profiles

    • Table Biomatik Production, Value, Price, Gross Margin 2014-2019

    • Table Biomatik Product benchmarking

    • Table Biomatik Strategic initiatives

    • Table Biomatik SWOT analysis

    • Table Exiqon Profiles

    • Table Exiqon Production, Value, Price, Gross Margin 2014-2019

    • Table Exiqon Product benchmarking

    • Table Exiqon Strategic initiatives

    • Table Exiqon SWOT analysis

    • Table Sigma-Aldrich Profiles

    • Table Sigma-Aldrich Production, Value, Price, Gross Margin 2014-2019

    • Table Sigma-Aldrich Product benchmarking

    • Table Sigma-Aldrich Strategic initiatives

    • Table Sigma-Aldrich SWOT analysis

    • Table IDT Profiles

    • Table IDT Production, Value, Price, Gross Margin 2014-2019

    • Table IDT Product benchmarking

    • Table IDT Strategic initiatives

    • Table IDT SWOT analysis

    • Table TAG Copenhagen Profiles

    • Table TAG Copenhagen Production, Value, Price, Gross Margin 2014-2019

    • Table TAG Copenhagen Product benchmarking

    • Table TAG Copenhagen Strategic initiatives

    • Table TAG Copenhagen SWOT analysis

    • Table Ella Biotech Profiles

    • Table Ella Biotech Production, Value, Price, Gross Margin 2014-2019

    • Table Ella Biotech Product benchmarking

    • Table Ella Biotech Strategic initiatives

    • Table Ella Biotech SWOT analysis

    • Table AM Biotechnologies LLC Profiles

    • Table AM Biotechnologies LLC Production, Value, Price, Gross Margin 2014-2019

    • Table AM Biotechnologies LLC Product benchmarking

    • Table AM Biotechnologies LLC Strategic initiatives

    • Table AM Biotechnologies LLC SWOT analysis

    • Table TriLink BioTechnologies Profiles

    • Table TriLink BioTechnologies Production, Value, Price, Gross Margin 2014-2019

    • Table TriLink BioTechnologies Product benchmarking

    • Table TriLink BioTechnologies Strategic initiatives

    • Table TriLink BioTechnologies SWOT analysis

    • Table Microsynth AG Profiles

    • Table Microsynth AG Production, Value, Price, Gross Margin 2014-2019

    • Table Microsynth AG Product benchmarking

    • Table Microsynth AG Strategic initiatives

    • Table Microsynth AG SWOT analysis

    • Table Syntezza Bioscience Profiles

    • Table Syntezza Bioscience Production, Value, Price, Gross Margin 2014-2019

    • Table Syntezza Bioscience Product benchmarking

    • Table Syntezza Bioscience Strategic initiatives

    • Table Syntezza Bioscience SWOT analysis

    • Table Bio Basic Profiles

    • Table Bio Basic Production, Value, Price, Gross Margin 2014-2019

    • Table Bio Basic Product benchmarking

    • Table Bio Basic Strategic initiatives

    • Table Bio Basic SWOT analysis

    • Table ThermoFisher Profiles

    • Table ThermoFisher Production, Value, Price, Gross Margin 2014-2019

    • Table ThermoFisher Product benchmarking

    • Table ThermoFisher Strategic initiatives

    • Table ThermoFisher SWOT analysis

    • Table Life biotech Profiles

    • Table Life biotech Production, Value, Price, Gross Margin 2014-2019

    • Table Life biotech Product benchmarking

    • Table Life biotech Strategic initiatives

    • Table Life biotech SWOT analysis

    • Table SGS DNA Profiles

    • Table SGS DNA Production, Value, Price, Gross Margin 2014-2019

    • Table SGS DNA Product benchmarking

    • Table SGS DNA Strategic initiatives

    • Table SGS DNA SWOT analysis

    • Table Bioneer Profiles

    • Table Bioneer Production, Value, Price, Gross Margin 2014-2019

    • Table Bioneer Product benchmarking

    • Table Bioneer Strategic initiatives

    • Table Bioneer SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US